Atlas Trials

A Phase2 of A-101 Topical Solution in Subjects With Common Warts

Clinical trial NCT03210337 · COMPLETED

Trial details

NCT number
NCT03210337
Sponsor
Aclaris Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Common Wart
Start date
2017-08-01
Primary completion
2018-03-16
Enrollment
157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.